Login / Signup

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial.

Vivek SubbiahJustin F GainorGeoffrey R OxnardDaniel S W TanDwight H OwenByoung Chul ChoHerbert Ho-Fung LoongCaroline E McCoachJared WeissYu Jung KimLyudmila BazhenovaKeunchil ParkHaruko DagaBenjamin BesseOliver GautschiChristian C RolfoEdward Y ZhuJennifer F KheraniXin HuangSuhyun KangAlexander E Drilon
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Selpercatinib has robust and durable intracranial efficacy in patients with RET fusion-positive NSCLC.
Keyphrases
  • small cell lung cancer
  • single cell
  • clinical trial
  • optic nerve
  • study protocol
  • phase iii
  • phase ii
  • advanced non small cell lung cancer
  • bone marrow
  • young adults
  • open label
  • tyrosine kinase
  • optical coherence tomography